Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a maintenance update to the study entry without changing its substantive details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now shows a newer ClinicalTrials.gov “Revision” version (v3.5.3) instead of the previous one (v3.5.2), reflecting an administrative/site update rather than a change to the trial record.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision history updated: v3.5.0 was removed. v3.5.2 was added.SummaryDifference0.0%

- Check57 days agoChange DetectedHb SS disease added to related terms and Genetic and Rare Diseases Information Center added under Resources.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 has been removed.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision tag updated to v3.4.3. The previous revision v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.